Clinical Trial Update: IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals

View source ↗

Summary

A clinical trial protocol studying IL-40 and IL-41 levels in sepsis, septic shock, and healthy individuals; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Melahat Yalcin Solak | Conditions: Sepsis, Septic Shock | Status: NOT_YET_RECRUITING